Tycoon Group Holdings Ltd. has announced a proposed issue of shares under a general mandate. The intended use of the proceeds from this subscription is to bolster their general working capital, preparing for any sudden financial changes, such as unexpected bank repayment demands. The board, excluding two dissenting directors, concluded that the subscription terms are fair and beneficial to the company and its shareholders. The subscriber, already a significant shareholder, is expected to increase its stake, potentially boosting stakeholder confidence and providing future collaboration opportunities with Jacobson Pharma Group. The company aims to stabilize its shareholder base with a lock-up agreement from the subscriber, who intends to hold the new shares long-term.